A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia

Previous preclinical studies and a phase I clinical trial suggested myo-inositol may be a safe and effective lung cancer chemopreventive agent. We conducted a randomized, double blind, placebo-controlled, phase IIb study to determine the chemopreventive effects of myo-inositol in smokers with bronch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Prev Res (Phila)
Main Authors: Lam, Stephen, Mandrekar, Sumithra J., Gesthalter, Yaron, Allen Ziegler, Katie L., Seisler, Drew K., Midthun, David E., Mao, Jenny T., Aubry, Marie Christine, McWilliams, Annette, Sin, Don D., Shaipanich, Tawimas, Liu, Gang, Johnson, Evan, Bild, Andrea, Lenburg, Marc E., Ionescu, Diana N., Mayo, John, Yi, Joanne (Eunhee), Tazelaar, Henry, Harmsen, William S., Smith, Judith, Spira, Avrum E., Beane, Jennifer, Limburg, Paul J., Szabo, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5136333/
https://ncbi.nlm.nih.gov/pubmed/27658890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-15-0254
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados